News
4 Analysts Have This To Say About Omega Therapeutics
7 May 24
Analyst Ratings
Chardan Capital Maintains Buy on Omega Therapeutics, Maintains $7 Price Target
7 May 24
News, Price Target, Analyst Ratings
Omega Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates
6 May 24
Biotech, Earnings, Earnings Misses, News, Penny Stocks, Markets, Trading Ideas, General
Omega Therapeutics Q1 2024 GAAP EPS $(0.36) Misses $(0.35) Estimate, Sales $2.360M Beat $1.630M Estimate
6 May 24
Earnings, Earnings Beats, Earnings Misses, News
HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $12 Price Target
30 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Omega Therapeutics Presents New Preclinical Data Supporting The Potential Of Precision Epigenomic Control At AACR 2024
9 Apr 24
News
Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9
3 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Omega Therapeutics Q4 2023 GAAP EPS $(0.37) Beats $(0.47) Estimate
28 Mar 24
Earnings, Earnings Beats, News
Press releases
Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome
7 May 24
Press Releases
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
6 May 24
Earnings, Press Releases
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
9 Apr 24
News, Press Releases
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
8 Apr 24
Press Releases
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
28 Mar 24
Earnings, Press Releases
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
19 Mar 24
Press Releases
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
6 Mar 24
News, Health Care, Press Releases